Anavex Life Sciences Corp.
AVXL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$11 | -$12 | -$12 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $1 | $2 | $2 |
| Change in WC | -$4 | $4 | -$2 | $3 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$12 | -$6 | -$12 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $0 | $0 | $4 |
| Financing Cash Flow | -$2 | $1 | $1 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$5 | -$11 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116 | $121 | $132 | $139 |
| End Cash | $101 | $116 | $121 | $132 |
| Free Cash Flow | -$12 | -$6 | -$12 | -$7 |